Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

27. März 2020 INDIZES USA

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...